Genentech’s buyout price increases 8 percent due to stronger U.S. dollar

ZURICH, Switzerland Roche will have to shell out a few more dollars for Genentech as the dollar rises against the Swiss franc.

Reuters reported that Citi analysts said the dollar’s 8 percent increase against the franc made the price for Genentech 8 percent more expensive. The $89 per share that Roche had offered is now $96.

The franc traded at 88 cents Friday.